Nearly 3% of the world's population suffers from the hepatitis C Virus (HCV). Most people who have hepatitis C received it from sharing needles or blood transfusions. There is currently no human vaccine for the hepatitis C virus because of the frequency of mutations it goes through.
Researchers at the University of Copenhagen recently developed a vaccine which protects mice from HCV. Since the virus mutates so frequently, developers Peter Holst, Prof. Allan Thomsen and associate professor Jan Christensen found a way to stimulate and accelerating the immune system. Also, the vaccine allows the body to attack parts of the virus which mutates less frequently. The vaccine has not yet been tested on humans, but is effective for mice.
If the vaccine works for humans, the spread of the hepatitis C Virus could stop spreading, if people at risk receive the vaccine. Before the development for a human HCV vaccine is produced, researchers must make a vaccine that works on macaque monkeys. The world may be a safer place from the virus of hepatitis C.
Posted by Reed Allen (1)